1217827-86-5 Usage
General Description
"(1S,4S)-2-benzyl-2,5-diazabicyclo[2.2.1]heptane-2HCl" is a chemical compound known for its complex structure. Its IUPAC name indicates its bicyclic nature, with two nitrogen atoms (diazabicyclo) incorporated into a seven-membered heptane ring, with two of the carbons replaced by nitrogens (2,5-diazabicyclo). The molecule also has a benzyl group attached, which is a phenyl group directly attached to a CH2 moiety. The "2HCl" denotes that this compound exists as a hydrochloride salt, meaning it contributes to two protons (H) and two chloride ions (Cl). Its CAS Registry Number is 1021298-68-9. It is important in scientific research, especially in the field of medicinal chemistry. However, information regarding its exact uses and properties is currently limited.
Check Digit Verification of cas no
The CAS Registry Mumber 1217827-86-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,8,2 and 7 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1217827-86:
(9*1)+(8*2)+(7*1)+(6*7)+(5*8)+(4*2)+(3*7)+(2*8)+(1*6)=165
165 % 10 = 5
So 1217827-86-5 is a valid CAS Registry Number.
1217827-86-5Relevant articles and documents
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
-
Page/Page column 135-136, (2020/02/16)
The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.
IDO INHIBITORS
-
Paragraph 1449, (2016/10/27)
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
INHIBITORS OF HISTONE DEACETYLASE
-
Page/Page column 167-168, (2008/12/07)
This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the inven- tion provides for compounds of formula (I) wherein (B), Q, J, L and Z are as defined in the specification
